Zweig-DiMenna Associates’s Profound Medical PROF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-104,261
| Closed | -$889K | – | 114 |
|
|
2024
Q1 | $889K | Sell |
104,261
-26,356
| -20% | -$225K | 0.08% | 108 |
|
|
2023
Q4 | $1.11M | Buy |
130,617
+43,343
| +50% | +$368K | 0.13% | 91 |
|
|
2023
Q3 | $890K | Sell |
87,274
-37,305
| -30% | -$381K | 0.11% | 97 |
|
|
2023
Q2 | $1.62M | Sell |
124,579
-86,196
| -41% | -$1.12M | 0.2% | 88 |
|
|
2023
Q1 | $1.96M | Sell |
210,775
-85,892
| -29% | -$798K | 0.27% | 79 |
|
|
2022
Q4 | $3.23M | Buy |
296,667
+31,000
| +12% | +$338K | 0.47% | 68 |
|
|
2022
Q3 | $1.07M | Buy |
265,667
+9,500
| +4% | +$38.4K | 0.23% | 70 |
|
|
2022
Q2 | $1.87M | Buy |
256,167
+14,500
| +6% | +$106K | 0.35% | 70 |
|
|
2022
Q1 | $2.18M | Buy |
241,667
+7,500
| +3% | +$67.5K | 0.29% | 73 |
|
|
2021
Q4 | $2.63M | Buy |
234,167
+12,500
| +6% | +$140K | 0.21% | 93 |
|
|
2021
Q3 | $3.25M | Hold |
221,667
| – | – | 0.23% | 106 |
|
|
2021
Q2 | $3.63M | Buy |
221,667
+40,078
| +22% | +$656K | 0.22% | 110 |
|
|
2021
Q1 | $3.66M | Sell |
181,589
-1,000
| -0.5% | -$20.1K | 0.25% | 106 |
|
|
2020
Q4 | $3.75M | Buy |
182,589
+64,500
| +55% | +$1.33M | 0.24% | 97 |
|
|
2020
Q3 | $2.08M | Sell |
118,089
-69,000
| -37% | -$1.22M | 0.14% | 113 |
|
|
2020
Q2 | $3.17M | Buy |
+187,089
| New | +$3.17M | 0.33% | 82 |
|